Iran Daru (XTEH:IRDR1) ROE % Adjusted to Book Value : 0.00% (As of . 20)

View and export this data going back to 1990. Start your Free Trial

What is Iran Daru ROE % Adjusted to Book Value?

Iran Daru's ROE % for the quarter that ended in . 20 was 0.00%. Iran Daru's PB Ratio for the quarter that ended in . 20 was N/A. Iran Daru's ROE % Adjusted to Book Value for the quarter that ended in . 20 was N/A.

Iran Daru ROE % Adjusted to Book Value Historical Data

The historical data trend for Iran Daru's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru ROE % Adjusted to Book Value Chart

Iran Daru Annual Data

Trend

ROE % Adjusted to Book Value

Iran Daru Semi-Annual Data

ROE % Adjusted to Book Value

Competitive Comparison of Iran Daru's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Iran Daru's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Iran Daru's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Iran Daru's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Iran Daru's ROE % Adjusted to Book Value falls into.

Iran Daru ROE % Adjusted to Book Value Calculation

Iran Daru's ROE % Adjusted to Book Value for the fiscal year that ended in . 20 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Iran Daru's ROE % Adjusted to Book Value for the quarter that ended in . 20 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Iran Daru ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Iran Daru's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Iran Daru (XTEH:IRDR1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111

Website

https://www.irandaru.com

Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines